Role of resveratrol in regulation of membrane transporters and integrity of human erythrocytes

Biochemical and Biophysical Research Communications

Volumn 453, Issue 3, 2014, Pages 521-526

  Pandey, Kanti Bhooshan ^a   Rizvi, Syed Ibrahim ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Erythrocytes; Membrane transporters; Oxidative stress; Resveratrol

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); RESVERATROL; SODIUM PROTON EXCHANGE PROTEIN; CARRIER PROTEIN; STILBENE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; HUMAN CELL; MALE; STIMULATION; STRESS; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS;

ERYTHROCYTES; HUMANS; MEMBRANE TRANSPORT PROTEINS; OXIDATIVE STRESS; STILBENES;

EID: 84918532088     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.09.117     Document Type: Article

References (41)

1. G.R. Dubyak, Ion homeostasis, channels, and transporters: an update on cellular mechanisms, Adv. Physiol. Educ. 28 (2004) 143-154.
2. F. Di Leva, T. Domi, L. Fedrizzi, D. Lim, E. Carafoli, The plasma membrane Ca2+ ATPase of animal cells: structure, function and regulation, Arch. Biochem. Biophys. 476 (2008) 65-74.
3. S.J. Reshkin, R.A. Cardone, S. Harguindey, Na+-H+ exchanger, pH regulation and cancer, Recent Pat. Anticancer Drug Discov. 8 (2013) 85-99.
4. M. Brini, T. Cali, D. Ottolini, E. Carafoli, The plasma membrane calcium pump in health and disease, FEBS J. 280 (2013) 5385-5397.
5. J. Reglinski, S. Hoey, W.E. Smith, R.D. Sturrock, Cellular response to oxidative stress at sulphydryl group receptor sites on the erythrocytes membrane, J. Biol. Chem. 263 (1988) 12360-12366.
6. K.B. Pandey, S.I. Rizvi, Biomarkers of oxidative stress in red blood cells, Biomed. Pap. 155 (2011) 131-136.
7. S.I. Rizvi, M.A. Zaid, Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins, Clin. Chim. Acta 354 (2005) 59-67.
8. K.B. Pandey, R. Jha, S.I. Rizvi, Erythrocyte membrane transporters during human ageing: modulatory role of tea catechins, Clin. Exp. Pharmacol. Physiol. 40 (2013) 83-89.
9. J.M. Smoliga, J.A. Baur, H.A. Hausenblas, Resveratrol and health - a comprehensive review of human clinical trials, Mol. Nutr. Food Res. 55 (2011) 1129-1141.
10. J.A. Baur, D.A. Sinclair, Therapeutic potential of resveratrol: the in vivo evidence, Nat. Rev. Drug Discov. 5 (2006) 493-506.
11. S. Timmers, J. Auwerx, P. Schrauwen, The journey of resveratrol from yeast to human, Aging (Albany NY) 4 (2012) 146-158.
12. K.B. Pandey, S.I. Rizvi, Resveratrol up-regulates the erythrocyte plasma membrane redox system and mitigates oxidation-induced alterations in erythrocytes during aging in humans, Rejuvenation Res. 16 (2013) 232-240.
13. K.B. Pandey, S.I. Rizvi, Protective effect of resveratrol on markers of oxidative stress in human erythrocytes subjected to in vitro oxidative insult, Phytother. Res. 24 (2010) S11-14.
14. K.B. Pandey, S.I. Rizvi, Protective effect of resveratrol on formation of membrane protein carbonyls and lipid peroxidation in erythrocytes subjected to oxidative stress, Appl. Physiol. Nutr. Metab. 34 (2009) 1093-1097.
15. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
16. M. Suhail, S.I. Rizvi, Red cell membrane (Na+/K+)-ATPase in diabetes mellitus, Biochem. Biophys. Res. Commun. 146 (1987) 179-186.
17. C.H. Fiske, Y. Subbarow, The colorimetric determination of phosphorus, J. Biol. Chem. 66 (1925) 375-400.
18. E. Matteucci, S.I. Rizvi, O. Giampietro, Erythrocyte sodium/hydrogen exchange inhibition by (-)epicatechin, Cell Biol. Int. 25 (2001) 771-776.
19. K.B. Pandey, S.I. Rizvi, Resveratrol in vitro ameliorates tert-butyl hydroperoxide-induced alterations in erythrocyte membranes from young and older humans, Appl. Physiol. Nutr. Metab. 31 (2014) 1-5.
20. S. Allo, T. Lincon, G.L. Wilson, et al., Non insulin dependent diabetes mellitus induced defect in cardiac calcium regulation, Am. J. Physiol. 260 (1991) 1165-1171.
21. R. Lopreiato, M. Giacomello, E. Carafoli, The plasma membrane calcium pump: new ways to look at an old enzyme, J. Biol. Chem. 289 (2014) 10261-10268.
22. B. Halliwell, J.M.C. Gutteridge, Cellular responses to oxidative stress: adaptation, damage, repair, senescence and death, in: B. Halliwell, J.M.C. Gutteridge (Eds.), Free Radicals in Biology and Medicine, Oxford University Press, New York, 2007, pp. 187-267.
23. Ch.V.R. Devi, V. Vidyullatha, G. Sandhya, et al., Alterations in calcium ATPase activity in erythrocyte membranes of non-insulin dependent diabetes mellitus patients, Rev. Biomed. 11 (2000) 1-5.
24. M. Kaneko, Y. Matsumoto, H. Hayashi, et al., Oxygen free radicals and calcium homeostasis in the heart, Mol. Cell. Biochem. 139 (1994) 91-100.
25. L. Wang, Q. Ma, X. Chen, H. Sha, Z. Ma, Effects of resveratrol on calcium regulation in rats with severe acute pancreatitis, Eur. J. Pharmacol. 580 (2008) 271-276.
26. M. Shen, R.X. Wu, L. Zhao, et al., Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism, PLoS One 7 (2012) e51223.
27. C.J. Tack, J.A. Lutterman, G. Vervoort, et al., Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans, Hypertension 28 (1996) 426-432.
28. D. Raccah, C. Fabreguetts, J.P. Azulay, P. Vague, Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients, Diabetes Care 19 (1996) 564-568.
29. T. Clausen, The Na+, K+ pump in skeletal muscle: quantification, regulation and functional significance, Acta Physiol. Scand. 156 (1996) 227-235.
30. R. Rodrigo, A. Miranda-Merchak, R. Valenzuela Grau, et al., Modulation of (Na, K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension, Clin. Exp. Hypertens. 36 (2014) 17-26.
31. M. Mense, G. Stark, H.J. Apell, Effects of free radicals on partial reactions of the Na, K-ATPase, J. Membr. Biol. 156 (1997) 63-71.
32. H. Rauchova, J. Ledvinkova, M. Kalous, Z. Drahota, The effect of lipid peroxidation on the activity of various membrane-bound ATPases in rat kidney, Int. J. Biochem. Cell Biol. 27 (1995) 251-261.
33. S. Selvaraj, A. Mohan, S. Narayanan, et al., Dose-dependent interaction of trans-resveratrol with biomembranes: effects on antioxidant property, J. Med. Chem. 56 (2013) 970-981.
34. S.L. Wu, L. Yu, X.Y. Jiao, et al., The suppressive effect of resveratrol on protein kinase C theta in peripheral blood T lymphocytes in a rat liver transplantation model, Transplant. Proc. 38 (2006) 3052-3054.
35. P. Xia, R.M. Kramer, G.L. King, Identification of the mechanism for the inhibition of Na+, K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2, J. Clin. Invest. 96 (1995) 733-740.
36. K.K. Wang, L.C. Wright, C.L. Machan, et al., Protein kinase C phosphorylates the carboxyl terminus of the plasma membrane Ca(2+)-ATPase from human erythrocytes, J. Biol. Chem. 266 (1991) 9078-9085.
37. J. Orlowski, S. Grinstein, Na+/H+ exchangers, Compr. Physiol. 1 (2011) 2083-2100.
38. S.J. Reshkin, A. Bellizzi, S. Caldeira, et al., Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes, FASEB J. 14 (2000) 2185-2197.
39. Z. Jhumka, S. Pervaiz, M.V. Clément, Resveratrol regulates the expression of NHE-1 by repressing its promoter activity: critical involvement of intracellular H2O2 and caspases 3 and 6 in the absence of cell death, Int. J. Biochem. Cell Biol. 41 (2009) 945-956.
40. M. Karmazyn, M. Sawyer, L. Fliegel, The Na(+)/H(+) exchanger: a target for cardiac therapeutic intervention, Curr. Drug Targets Cardiovasc. Haematol. Disord. 5 (2005) 323-335.
41. R.J. Gumina, T. Mizumura, N. Beier, et al., A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infract size in dogs when administered before or after coronary artery occlusion, J. Pharmacol. Exp. Ther. 286 (1998) 175-183.